The Effects of Different Doses of Dexmedetomidine on Propofol Requirement for Loss of Consciousness Undergoing Bispectral Index: a Double-blinded, Placebo-controlled Trial

Loss of Consciousness Clinical Trial

Official title:
The Effects of Different Dexmedetomidine on the Propofol Requirement for Loss of Consciousness Undergoing Bispectral Index

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the effects of different dexmedetomidine on the propofol requirement for loss of consciousness undergoing bispectral index.

Clinical Trial Description

It has been shown that dexmedetomidine was an efficacious and safe adjuvant in general anaesthesia. Administration of dexmedetomidine during the preoperative period has been demonstrated to reduce the requirement of opioid analgesics and other sedative and hypnotic drugs.Therefore, the study is designed to measure the effect of intravenous dexmedetomidine premedication on the propofol dose requirement and bispectral index at loss of consciousness. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02783846
Study type	Interventional
Source	General Hospital of Ningxia Medical University
Contact
Status	Completed
Phase	N/A
Start date	June 2016
Completion date	August 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04502550` - Brain Networks and Consciousness
Completed	`NCT04901871` - Remimazolam Bolus for General Anesthesia	Phase 3
Completed	`NCT02125214` - Alteration of Temporal Organization of EEG Microstate Sequences During Propofol-induced Loss of Consciousness	N/A
Completed	`NCT02831101` - Sufentanil Bispectral Index Elderly	N/A
Terminated	`NCT00143754` - Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained Syncope	Phase 3